Gene Therapy
New gene therapy research has been reported by scientists in the United States and the detriment of RNAi gene therapy turns out to be that it uses the body's own machinery
Published in Health Business Week, June 29th, 2007
Study 1: Data detailed in "Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment" have been presented. According to a study from the United States, "The World Federation of Hemophilia estimates that of the 400,000 individuals worldwide with hemophilia, 300,000 receive either no, or very sporadic, treatment. Thus, considerable innovation will be required to provide cost-effective therapies/cures for all affected individuals."
"The high cost of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-06-29)
More Articles from Health Business Week
- A.P. Pharma, Inc.
A.P. Pharma Prices $35 Million Common Stock Offering - AARP
AARP Members Rally on Capital Lawn in Albany for Prescription Drug Marketing Reform - AARP
AARP, Business Roundtable and SEIU Deliver Endorsed Health IT Principles to Congress - AARP
Leading National Organizations and Physicians Call on New York State to Lead Nation in Rx Marketing Reform - Abbott
Abbott Declares 334th Consecutive Quarterly Dividend - Acacia Research Corporation
SEC Declares CombiMatrix S-1 Registration Statement Effective - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
